1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63A50A252C2F7C3D285256F6300716D43
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/sales-force-enthusiasm-garnering-support-for-product-re-launch?opendocument
18
19opendocument
203.85.214.0
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Re-launch

Sales Force Enthusiasm: Garnering Support for Product Re-Launch

DB Image

ID: 4774


Features:

Metrics, Graphics


Pages/Slides: 19


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

Non-members: Click here to sign-up for a complimentary tour of
"Sales Force Enthusiasm: Garnering Support for Product Re-Launch"


Study Overview
Garnering sales force support for a re-launched pharmaceutical product can be a Sisyphean effort. Sales teams may be skeptical that they can sell the re-launched product and make quotas. Or, the sales team itself may be the reason for the initial launch failure. This research will assist brand executives in getting sales force support for a re-launch effort.

Key topics

  • Aligning sales force tactics with product re-launch strategy
  • Creating excitement and support
  • Shifting product placement
  • Equipping the sales force for re-launch success
  • Shifting resources to ensure success

Sample Best Practices
  • Add fresh new sales force support to build excitement about the re-launch.
  • *Not all re-launches will win expanded sales force resources. Nevertheless, benchmark partners noted that increasing sales team size helps to ensure field coverage and selling power.
  • Ensure that the sales data management systems are adequate to track field performance and permit plan adjustments that may be required to penetrate target customer segments.
  • *The ability to rapidly measure sales performance and track ongoing market progress is important for any sales organization; however, during launch and re-launch cycles, this data management capability is essential.

Methodology
This research originated from a consulting project with a large pharmaceutical client.

Industries Profiled:
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Biotech; Health Care


Companies Profiled:
Bayer Healthcare; UCB Pharma; Schering-Plough; Roche; Pfizer; Novartis; Merck; AstraZeneca; DSM Pharmaceutical; Sanofi-aventis; Abbott Laboratories; Eli Lilly; GlaxoSmithKline l

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.